Copyright
©The Author(s) 2025.
Artif Intell Gastroenterol. Jun 8, 2025; 6(1): 108198
Published online Jun 8, 2025. doi: 10.35712/aig.v6.i1.108198
Published online Jun 8, 2025. doi: 10.35712/aig.v6.i1.108198
Table 2 Studies summarizing the role of artificial intelligence in response prediction and prognostication
No. | Title of study | Ref. | Sample size | Validation method | Key limitations |
1 | Machine learning in gastrointestinal surgery | Sakamoto et al[31] | N/A | Mixed internal and external | Lack of detailed validation cohort; small sample sizes |
2 | A histopathology-based AI system for genetic alteration screening in intrahepatic cholangiocarcinoma | Xiao et al[32] | 100+ patients | Internal | Small sample size, lack of external validation |
3 | A nomogram based on a collagen feature SVM for predicting treatment response in rectal cancer | Jiang et al[33] | 200+ patients | External | Single-center data, limited generalizability |
4 | A novel classification of intrahepatic cholangiocarcinoma phenotypes using ML | Tsilimigras et al[34] | 150+ patients | External | Limited external validation in diverse populations |
5 | AI system for pathologic outcome prediction in early gastric cancer | Lee et al[36] | 300+ patients | External | Lack of long-term follow-up data |
6 | AI-based recognition model for colorectal liver metastases in intraoperative ultrasound | Takayama et al[37] | 100+ patients | External | Single-center validation, limited scalability |
7 | Analysis of methionine metabolism and macrophage-related patterns in hepatocellular carcinoma | Wen et al[38] | 200+ patients | External | Requires further clinical validation in diverse cohorts |
8 | AI and ML predicting transarterial chemoembolization outcomes | Cho et al[39] | 100+ patients | Mixed internal and external | Inconsistent prediction performance across centers |
9 | AI based on serum biomarkers predicts efficacy of lenvatinib in hepatocellular carcinoma | Hsu et al[40] | 100+ patients | Internal | Needs multi-center validation |
10 | AI-enabled histological prediction of remission or activity in ulcerative colitis | Iacucci et al[41] | 150+ patients | External | Lack of long-term clinical outcomes, limited sample size |
11 | AI for lymph node metastasis prediction in gastric cancer | Yan et al[42] | 500+ gastric cancer patients | External | Limited multi-center validation, needs wider cohort testing |
12 | AI in gastrointestinal cancers: Diagnostic, prognostic, and surgical strategies | Nagaraju et al[43] | N/A | N/A | Lacks detailed validation or large cohorts |
13 | AI in perioperative management of major gastrointestinal surgeries | Solanki et al[44] | 300+ patients | External | Limited by single-center studies; needs broader cohort validation |
14 | AI system to determine risk of colorectal cancer metastasis | Kudo et al[45] | 200+ patients | External | Validation needed in multi-center settings |
15 | AI-driven patient selection for preoperative portal vein embolization | Kuhn et al[46] | 150+ patients | External | Requires larger-scale studies to confirm findings |
16 | Comparison of models for predicting quality of life after hepatocellular carcinoma surgery | Chiu et al[47] | 100+ patients | Mixed internal and external | Limited external validation and long-term data |
17 | ML survival framework for pancreatic cancer | Wang et al[48] | 300+ pancreatic cancer patients | Internal | Lack of multi-center validation; small sample size |
18 | Deep learning model for predicting hepatocellular carcinoma recurrence | Liu et al[86] | 200+ patients | External | Need for larger cohort validation |
- Citation: Agrawal H, Gupta N, Tanwar H, Panesar N. Artificial intelligence in gastrointestinal surgery: A minireview of predictive models and clinical applications. Artif Intell Gastroenterol 2025; 6(1): 108198
- URL: https://www.wjgnet.com/2644-3236/full/v6/i1/108198.htm
- DOI: https://dx.doi.org/10.35712/aig.v6.i1.108198